dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
News articleYahoo Finance· November 4, 2026

Siltronic AG (SSLLF) (Q3 2026) Earnings Call Highlights: Record 300mm Shipments Drive Sales Up ...

View original at finance.yahoo.com
“EBITDA: Increased from EUR69 million in Q2 to EUR81 million in Q3 2026.”
Verbatim excerpt from the source · Yahoo Finance · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • 2026 depreciation expected at EUR480 million-EUR500 million, slightly below the prior EUR490 million-EUR520 million range.

    60% confidence
  • 2026 capex guidance is EUR180 million-EUR200 million, from EUR180 million-EUR220 million.

    60% confidence
  • 2026 EBIT expected significantly below the previous year (unchanged); 2026 net cash flow expected around the previous year's level (unchanged).

    60% confidence
  • Net interest expense is expected around EUR30 million for full year 2026; Q4 guidance assumes an EUR-USD rate of 1.14.

    60% confidence
  • The new Singapore fab ramp is progressing well and was no longer dilutive to group EBITDA margin in Q3.

    60% confidence
  • 2026 EBITDA margin guidance narrowed to 22%-24%, the upper end of the previous 20%-24% range.

    60% confidence
  • 300mm shipments reached an all-time high in Q3 2026, and wafer volumes increased QoQ across both 200mm and 300mm.

    60% confidence
  • 2026 sales are now expected in the range of 2025, versus prior low-to-mid-single-digit decline; like-for-like sales expected to exceed last year.

    60% confidence

Cité dans ces articles de Via News

Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,997
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,997 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
Siltronic AG (SSLLF) (Q3 2026) Earnings Call Highlights: Record 300mm Shipments Drive Sales Up ...: Source | Via News | fr.via.news